Financial Data and Key Metrics Changes - In Q4 2025, net sales reached $1.3 billion, reflecting a year-over-year growth of 6.3% [6][18] - For the full year, net sales increased nearly 1% to just over $5 billion, with an adjusted EBITDA of $658 million and a margin of 13.1% [8][18] - The total leverage ratio improved to 2.8x, down from 3.9x at the end of 2023, indicating stronger financial health [5][33] Business Line Data and Key Metrics Changes - North America experienced a 19% increase in new distributors in Q4, marking its second consecutive quarter of double-digit growth [9] - Latin America achieved its seventh consecutive quarter of year-over-year growth, with reported net sales up 18% [26] - The Asia Pacific region saw a 5% increase in reported net sales, driven by approximately 9% volume growth [27] Market Data and Key Metrics Changes - India delivered its highest quarterly net sales in Q4, with a 15% year-over-year increase, attributed to a reduction in the goods and services tax [19][27] - North America sales declined by less than 1% year-over-year, consistent with prior expectations [27] - China reported a 4% decline in net sales year-over-year, primarily due to an 11% decrease in volume [28] Company Strategy and Development Direction - The company aims to be the world's premier health and wellness platform, focusing on innovation and digital engagement [5][11] - Plans include launching personalized nutritional supplements and enhancing the distributor experience through digital tools [12][15] - The partnership with Cristiano Ronaldo is expected to elevate brand visibility and expand market reach [16][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strategy and ability to execute, highlighting a strong foundation for future growth [17][38] - The company anticipates net sales growth in all regions except China for 2026, with a focus on leveraging the GST benefits in India [43][46] - Adjusted EBITDA guidance for Q1 2026 is set between $155 million to $175 million, with full-year expectations of $670 million to $710 million [35] Other Important Information - The company has repaid $283 million of debt in 2025, contributing to a stronger balance sheet [8][33] - A presentation change was made to better align distributor-related compensation reporting, with no impact on prior period results [31] Q&A Session Summary Question: Guidance on sales for different geographic segments in 2026 - Management expects net sales growth in every region except China, which is anticipated to improve in 2027 [42][43] Question: Expectations for Pro2col sales contribution - Minimal top-line contribution is built into guidance, with more upside potential as the program is in beta phase [44][45] Question: Growth in energy, sports, and fitness product categories - This category has historically outpaced overall performance, with successful launches contributing to growth [51] Question: Expansion of nutrition club infrastructure - The Breakfast Budget Clubs model is gaining traction in the UK and is being introduced in other markets [53][54] Question: Distributor retention rates and training programs - Improved retention is attributed to various support programs, enhancing distributor education and strategy [55][56] Question: Contribution of new products to sales growth - Successful product launches, including MultiBurn and HL Skin, have significantly contributed to sales [61] Question: Plans for distributor events in 2026 - The company plans to increase the number of events, with costs expected to rise slightly more than sales [62][64] Question: Strategy for evolving product offerings and customer base - The company aims to attract a more sophisticated customer base while deepening engagement with existing customers [71][73] Question: Impact of GST changes in India on sales - The reduced GST is expected to provide a tailwind until it laps in late September 2026 [77][78] Question: Relationship between distributor growth and member growth - Both distributor and preferred member growth are important, with adjustments made to focus on preferred customers [83][86]

Financial Data and Key Metrics Changes - In Q4 2025, net sales reached $1.3 billion, reflecting a year-over-year growth of 6.3% [6][18] - For the full year 2025, net sales increased nearly 1% to just over $5 billion, with an adjusted EBITDA of $658 million and a margin of 13.1% [8][18] - The total leverage ratio improved to 2.8x from 3.9x at the end of 2023, indicating stronger cash generation [5][33] Business Line Data and Key Metrics Changes - North America experienced a 19% increase in new distributors in Q4, marking its second consecutive quarter of double-digit growth [9] - Latin America achieved its seventh consecutive quarter of year-over-year growth, with reported net sales up 18% [26] - The Asia Pacific region saw reported net sales increase by 5% year-over-year, driven by volume growth [27] Market Data and Key Metrics Changes - India delivered its highest quarterly net sales in Q4, with a 15% increase year-over-year, attributed to a reduction in the Goods and Services Tax [19][27] - North America sales declined slightly by less than 1% year-over-year, consistent with prior expectations [27] - China reported a 4% decline in net sales year-over-year, primarily due to an 11% decrease in volume [28] Company Strategy and Development Direction - The company aims to be the world's premier health and wellness platform, focusing on innovation and digital engagement [5][11] - Plans include launching personalized nutritional supplements and enhancing the distributor experience through the Pro2col technology [12][15] - The partnership with Cristiano Ronaldo is expected to elevate brand visibility and expand customer engagement [16][74] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strategy and ability to execute, highlighting a strong foundation for long-term growth [17][37] - The company anticipates net sales growth in all regions except China for 2026, with a focus on leveraging the GST benefits in India [43][46] - The adjusted effective tax rate is expected to be approximately 30% for 2026, aligning with 2025 [36] Other Important Information - The company repaid $283 million of debt in 2025, contributing to a stronger financial profile [8][33] - Adjusted net income for Q4 was $48 million, with an adjusted diluted EPS of $0.45 [22][23] - The company has implemented a strategic phased beta rollout for Pro2col, enhancing distributor engagement [12][13] Q&A Session Summary Question: Guidance on sales for different geographic segments in 2026 - Management expects net sales growth in every region except China, which is anticipated to be a 2027 event [43] Question: Expectations for Pro2col's sales contribution - Very little top-line contribution is built into the current guidance, with more upside than risk anticipated [44] Question: Contribution of product categories to sales growth - The energy, sports, and fitness category has outpaced overall company performance, with successful product launches contributing to growth [51] Question: Expansion of Nutrition Clubs in Europe - The Breakfast Budget Clubs model is gaining interest, with training programs being conducted to support distributors [53] Question: Retention rates of Sales Leaders - Improved retention is attributed to better education and support programs for distributors [55] Question: Future distributor events and spending - The company plans to increase the number of events, with costs expected to rise slightly more than sales [62][64] Question: Strategy for evolving product offerings and customer base - The company aims to attract a more sophisticated customer base while deepening engagement with existing customers [71][73]

Financial Data and Key Metrics Changes - In Q4 2025, net sales reached $1.3 billion, reflecting a year-over-year growth of 6.3% and marking the second consecutive quarter of growth [5][17] - For the full year, net sales increased nearly 1% to just over $5 billion, with an adjusted EBITDA of $658 million and a margin of 13.1%, indicating expansion for the second consecutive year [6][35] - The total leverage ratio improved to 2.8x from 3.9x at the end of 2023, highlighting a stronger financial foundation [4][31] Business Line Data and Key Metrics Changes - North America experienced a 19% increase in new distributors year-over-year, while Latin America achieved its seventh consecutive quarter of growth [7][8] - The energy, sports, and fitness product category was the fastest-growing segment in 2025, driven by successful product launches [51][62] Market Data and Key Metrics Changes - India reported its highest quarterly net sales in Q4, with a 15% increase year-over-year, attributed to a reduction in the goods and services tax rate [18][26] - Latin America saw reported net sales growth of 18%, with local currency results up 11%, driven by favorable pricing and volume growth [25][26] - In Asia Pacific, reported net sales increased by 5% year-over-year, with a 9% volume growth [26] Company Strategy and Development Direction - The company aims to be the world's premier health and wellness platform, focusing on innovation and digital engagement to enhance distributor success [4][10] - Plans for 2026 include launching new products and modernizing the digital ecosystem to improve customer engagement and personalization [10][11] - The partnership with Cristiano Ronaldo, who acquired a 10% equity stake in Pro2col Software, is expected to elevate brand visibility and expand market reach [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strategy and ability to execute, anticipating net sales growth in all regions except China for 2026 [40][41] - The reduction in GST in India is expected to provide a tailwind for sales until late 2026, despite some margin pressures from increased costs [46][79] - The company is committed to reducing gross debt to $1.4 billion by the end of 2028 while continuing to explore small acquisitions to enhance its core business [31][92] Other Important Information - Adjusted EBITDA for Q4 was $156 million, exceeding guidance, while the adjusted net income for the quarter was $48 million [19][20] - The company has implemented a strategic phased beta rollout of its health and wellness operating system, Pro2col, to enhance distributor engagement [12][13] Q&A Session Summary Question: Can you provide guidance on sales for different geographic segments in 2026? - Management expects net sales growth in every region except China, which is anticipated to be a 2027 event [40] Question: What are the expectations for sales contribution from Pro2col? - Very little top-line contribution is built into the current guidance, with more upside than risk anticipated from the Pro2col program [41][42] Question: How did the energy, sports, and fitness category perform in 2025? - This category has consistently outpaced overall company performance, with successful product launches contributing to growth [51] Question: What is the strategy for expanding the nutrition club infrastructure? - The company is conducting training in various regions, including Europe, to expand the nutrition club model [53][54] Question: What factors contributed to improved Sales Leaders retention rates in 2025? - Various training programs and support initiatives have contributed to the retention of Sales Leaders [56][57] Question: How does the company plan to approach product-customer fit with evolving offerings? - The company aims to attract a more sophisticated customer base while deepening engagement with existing customers [70][73]

Group 1: Kao Corporation - Kao Corporation participated in the 8th China International Import Expo with the theme "Co-creating Beauty, Quality for the Future," showcasing its global innovation and local integration achievements [3] - The company presented a range of products tailored for the Chinese market, including upgraded cleansing oils and sunscreen solutions, emphasizing its commitment to high-quality living for Chinese consumers [4] Group 2: Nippon Paint and GAC Aion - Nippon Paint and GAC Aion announced a strategic partnership during the expo, focusing on the development of coatings for flying cars and lightweight material protection, aiming to enhance the quality of China's low-altitude economy [6] - GAC Aion's AirCab is in the civil aviation certification phase, with plans for mass production in late 2026 and manned flights in 2027, while Nippon Paint introduced a comprehensive coating solution for low-altitude flying vehicles [6] Group 3: LEGO Group - LEGO Group showcased an immersive "City of Play" at the expo, featuring eight themed areas and a model of Shanghai made from nearly 100,000 bricks, promoting cultural connection and sustainability [8][10] - The company hosted multiple activities during the event, including global product launches and sustainability discussions, reinforcing its commitment to engaging with Chinese consumers [8] Group 4: Bayer - Bayer launched the "Allergy Star Survival Guide" during the expo, focusing on the prevention and treatment of allergic diseases, which affect nearly 250 million people in China [11] - The initiative aims to shift from passive treatment to proactive management of allergies, emphasizing the importance of early intervention and appropriate medication [11] Group 5: Herbalife - Herbalife introduced its MultiBurn supplement at the expo, targeting weight management through a blend of plant extracts that support metabolism and fat reduction [14] - The company highlighted the importance of a scientific approach to weight management, aligning with consumer demands for effective and sustainable health solutions [14]

Core Insights - The eighth China International Import Expo (CIIE) showcased 461 new products, technologies, and services, establishing itself as a platform for global innovation and market entry [2] - Major global companies in the medical device and healthcare sectors, including Johnson & Johnson, Roche, and Pfizer, participated, highlighting the expo's role in promoting high-end medical equipment and innovative pharmaceuticals [2][3] - The expo has accelerated the registration and market entry processes for new medical products, exemplified by Medtronic's Micra product, which achieved rapid commercialization following its global debut at the first CIIE [3] Medical Devices and Healthcare - The expo featured significant innovations such as Johnson & Johnson's ETHICON 4000 3D stapler and Siemens Healthineers' ARTIS icono ceiling Xpand, indicating a shift in China's high-end medical device sector from "catching up" to "leading" [2] - Medtronic's focus on AI integration in healthcare was evident with the introduction of seven new products, showcasing the company's commitment to innovation in the medical field [2][3] - The integration of clinical practitioners and entrepreneurs is expected to foster more original innovations in the healthcare sector [2] Consumer Trends - The expo introduced new themes such as the silver economy, ice and snow economy, and sports economy, along with platforms for digital and health consumption, enhancing consumer experiences [3] - Companies like JoShan Health Technology showcased an AI-driven health management ecosystem, reflecting a trend towards personalized and intelligent home fitness solutions [4] Economic Impact - Panasonic highlighted its innovative products aimed at enhancing quality of life, emphasizing the dual focus on user scenarios and AI industry infrastructure development in China [5] - Shanghai has rapidly developed its first-launch economy, hosting over 2,000 first-launch events this year and seeing significant growth in e-commerce transactions, with a 12.7% year-on-year increase [5]

Financial Data and Key Metrics Changes - Herbalife reported Q3 net sales of $1.3 billion, up 2.7% year-over-year, marking the first quarter of net sales growth since Q1 2024 [5][20] - Adjusted EBITDA for Q3 was $163 million, exceeding guidance, with an adjusted EBITDA margin of 12.8%, down 60 basis points year-over-year [22][24] - The total leverage ratio was reduced to 2.8 times, outperforming the three-times commitment, with strong operating cash flows of $139 million, up 40% from Q3 2024 [24][20] Business Line Data and Key Metrics Changes - North America achieved its first quarterly growth since Q2 2021, with net sales up 1% year-over-year, driven by favorable pricing on flat volumes [27][21] - Latin America reported a solid quarter with net sales up 11% year-over-year, primarily due to favorable pricing impacts and improved sales mix [25] - EMEA net sales increased 4% on a reported basis, while Asia-Pacific remained relatively flat, indicating mixed performance across regions [26][28] Market Data and Key Metrics Changes - North America saw a significant sequential improvement in year-over-year net sales trend by approximately 480 basis points [27] - China experienced a decline in net sales by 5% year-over-year, primarily due to a 12% decline in volumes [28] - India reported a 4% increase in net sales on a reported basis, driven by favorable pricing and a 5% increase in volume [26] Company Strategy and Development Direction - Herbalife aims to be the world's premier health and wellness company, focusing on personalized nutrition and leveraging technology to enhance distributor engagement [4][9] - The company is introducing Protocol, a next-generation digital personalized health operating system, to deepen engagement and drive growth [6][8] - Linked Bioscience acquisition will enable Herbalife to deliver precision-made supplements tailored to individual needs, enhancing its competitive edge [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's transformation, highlighting strong cash flow, reduced leverage, and targeted investments in innovation [17][35] - The company anticipates continued growth in net sales and adjusted EBITDA for Q4, with guidance reflecting currency volatility [31][33] - Management emphasized the importance of personalized nutrition and the role of distributors in driving business success [60][61] Other Important Information - Herbalife launched new products, including HL Skin and Baseline, showcasing its ability to innovate and respond to global health trends [15][17] - The company opened a new state-of-the-art R&D facility in Torrance, California, to enhance product development capabilities [12][14] - Engagement metrics from the Protocol beta group indicate strong distributor participation and enthusiasm for new technology [7][39] Q&A Session Summary Question: Capital allocation and debt reduction strategy - Management clarified that the focus remains on reducing debt while exploring opportunities for internal investments [36][37] Question: Costs associated with new product introductions - Management indicated that there would be no significant increase in SG&A costs related to distributor education on new products [38] Question: Early responses from the Protocol beta group - Feedback from the beta group has been positive, with high engagement levels and valuable insights for product development [39][40] Question: New distributor growth and productivity - The growth in new distributors is attributed to excitement about future products and ongoing engagement initiatives [42] Question: AI development for skincare products - The AI tool for skincare was developed in partnership and has shown impressive engagement metrics since launch [44] Question: Volume growth drivers and product mix - There is a slight shift towards healthy active lifestyle products, with a renewed focus on weight loss due to the launch of MultiBurn [45][47] Question: Expansion of the Mastermind program in India - The program has received positive feedback and is seen as essential for sustaining growth in the region [48][49] Question: Subscription revenue opportunities - Management believes subscription revenue will play a significant role in the future, with ongoing developments in this area [57][58]

Financial Performance - Q2 2025 net sales reached $1.3 billion, aligning closely with the midpoint of the company's guidance range[12] - Adjusted EBITDA for Q2 2025 was $174 million, surpassing the company's guidance[12] - The company repaid $55 million in debt, including $50 million of 2025 Notes[12] - The company's gross profit margin increased by 10 bps year-over-year to 78%[31] - Adjusted diluted EPS was $0.59, which includes an $0.11 year-over-year foreign exchange headwind[31] Regional Performance - New distributor growth occurred in 4 out of 5 regions year-over-year, with Latin America leading at a 16% increase[12] - Worldwide net sales decreased by 1.7% year-over-year, but remained flat on a constant currency basis[34] - Latin America experienced a 9% increase in local currency net sales[34] Product Launches and Initiatives - The company launched the Herbalife Flex45 Challenge globally[12] - The company expanded the Diamond Development Mastermind Program to South and Central America[12] - The company launched MultiBurn, a multifunctional weight-loss supplement[12] - The company unveiled the beta version of the Pro2col digital platform[12] Future Outlook - The company projects net sales to increase between 0.5% and 4.5% year-over-year for Q3 2025[42] - The company anticipates adjusted EBITDA between $150 million and $160 million for Q3 2025[42] - The company expects full-year 2025 net sales to range from a decrease of 1% to an increase of 3% year-over-year[42]